Posted On: 09/15/2013 10:44:58 AM
Post# of 72446
It just may be a hidden gem. I think you are on to something. I started reading a bit more into the earlier years of polymedix.
Basically it is a computer-based technology that uses mathematical modeling and algorithms to design the compounds. So instead of going through the normal approach of trial and error in the lab they let the computer try to mimic the proteins. Then they can test the product in the lab once they have synthesized it. It will cut down on lost time through bad drug design and increase the chances the drugs will work as expected.
The one thing I do not understand is the patent for the technology is not assigned to polymedix. It may be that it is exclusively licensed by them. which is good with either way. If CTIX gets to use it then it is a win, win situation. It is not solely for developing antibacterials.
This technology can be used to develop any type of drug that uses proteins as its basis. Which is I am going to guess and say 97% of current drug design but it may be closer to 99.9%. I just don't want to research who isn't using proteins . It looks like polymedix was focusing its use first in antibiotics.
I found an awesome interview with CEO from 2003 that would clarify what this is better then I can. What I love about the interview is how he said that mathematically there are 10 to the 83 drugs that can be made and so far (2003) there have only been about 100 billion attmepted, which is like 0.0000000000000000000000000000001% (probably more zeros, HEHE) of the available compounds which MIGHT work in the human body, in the last century. It makes you wonder where in that computer software is the cure for HIV and everything else
So the patent number to look it up is 7,590,517
and the website with the CEO interview is http://www.twst.com/interview/16845
Basically it is a computer-based technology that uses mathematical modeling and algorithms to design the compounds. So instead of going through the normal approach of trial and error in the lab they let the computer try to mimic the proteins. Then they can test the product in the lab once they have synthesized it. It will cut down on lost time through bad drug design and increase the chances the drugs will work as expected.
The one thing I do not understand is the patent for the technology is not assigned to polymedix. It may be that it is exclusively licensed by them. which is good with either way. If CTIX gets to use it then it is a win, win situation. It is not solely for developing antibacterials.
This technology can be used to develop any type of drug that uses proteins as its basis. Which is I am going to guess and say 97% of current drug design but it may be closer to 99.9%. I just don't want to research who isn't using proteins . It looks like polymedix was focusing its use first in antibiotics.
I found an awesome interview with CEO from 2003 that would clarify what this is better then I can. What I love about the interview is how he said that mathematically there are 10 to the 83 drugs that can be made and so far (2003) there have only been about 100 billion attmepted, which is like 0.0000000000000000000000000000001% (probably more zeros, HEHE) of the available compounds which MIGHT work in the human body, in the last century. It makes you wonder where in that computer software is the cure for HIV and everything else
So the patent number to look it up is 7,590,517
and the website with the CEO interview is http://www.twst.com/interview/16845
(0)
(0)
